Skip to content

Assessment of Body Composition Via Dual-energy X-ray Absorptiometry Bone Densitometry

Assessment of Body Composition Via Dual-energy X-ray Absorptiometry Bone Densitometry: Cross Calibration and Reproducibility Between the Stratos DR and Discovery A Bone Densitometers

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02609191
Acronym
STRATOS
Enrollment
50
Registered
2015-11-20
Start date
2016-06-30
Completion date
2017-06-01
Last updated
2025-11-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteodensitometry

Brief summary

The main objective of this study is to validate the measurement characteristics of a new bone densitometer, the Stratos DR: * Via cross calibration to the results of body composition (BC) measurement results to those of a reference device (the Discover A by Hologic) in terms of body fat percentage, lean mass percentage of total body mass and for different subregions (left and right arms, left and right sides, lumbar and thoracic spine, pelvis, left and right legs, head, android area, gynecoid area, visceral region). * And by the evaluation of the reproducibility of the BC measurement results in terms of fat mass and lean mass.

Detailed description

The secondary objective of this study is to cross calibrate the measures of bone mineral content (BMC) and bone mineral density (BMD) from the Stratos DR against those of the Discovery A on the whole body and its subregions.

Interventions

DEVICEWhole body exam using the Discovery A

Whole body exam using the Discovery A machine made by Hologic.

DEVICEFirst whole body exam using the Stratos DR

First whole body exam using the Stratos DR machine made by the DMS group.

DEVICESecond whole body exam using the Stratos DR

Second whole body exam using the Stratos DR machine made by the DMS group. This second exam is required for reproducibility purposes.

Sponsors

DMS Apelem
CollaboratorINDUSTRY
Centre Hospitalier Universitaire de Nīmes
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* The patient must have given his/her informed and signed consent * The patient must be insured or beneficiary of a health insurance plan * The patient is referred by a doctor for the performance of an osteodensitometry examination.

Exclusion criteria

* The patient is participating in another study * The patient is in an exclusion period determined by a previous study * The patient is under judicial protection or any kind of guardianship * The patient refuses to sign the consent * It is impossible to correctly inform the patient * The subject is suffering from a visually significant scoliosis * The patient is pregnant or breastfeeding * Patient weighing over 160 kg * Patient having undergone X-ray examination using a contrast medium such as barium in the 7 days preceding the visit * Patient who underwent an examination using γ rays in the 15 days preceding the visit

Design outcomes

Primary

MeasureTime frameDescription
Lin concordance coefficient for fat massDay 0The cross calibration between the two devices (Stratos vs Discovery) in terms of fat mass and lean mass is estimated by the appreciation of the Lin concordance coefficient.
Lin concordance coefficient for lean massDay 0The cross calibration between the two devices (Stratos vs Discovery) in terms of fat mass and lean mass is estimated by the appreciation of the Lin concordance coefficient.
RMS-%CV (root-mean-square coefficient of variation) for total fat massDay 0Reproducibility will be evaluated in terms of RMS-% CV for calculating the value of the least significant change (LSC). The values of RMS-%CV (root-mean-square coefficient of variation) of the total fat mass and total lean mass will be compared with the limit values recommended by the ISCD. (International Society for Clinical Densitometry)
RMS-%CV (root-mean-square coefficient of variation) for total lean massDay 0Reproducibility will be evaluated in terms of RMS-% CV for calculating the value of the least significant change (LSC). The values of RMS-%CV (root-mean-square coefficient of variation) of the total fat mass and total lean mass will be compared with the limit values recommended by the ISCD. (International Society for Clinical Densitometry)

Secondary

MeasureTime frameDescription
Lin's concordance coefficient for Bone Mineral ContentDay 0The cross calibration between the two devices (Stratos vs Discovery) in terms of Bone Mineral Content and Bone Mineral Density will be estimated by the study of Lin's concordance coefficient.
Lin's concordance coefficient for Bone Mineral DensityDay 0The cross calibration between the two devices (Stratos vs Discovery) in terms of Bone Mineral Content and Bone Mineral Density will be estimated by the study of Lin's concordance coefficient.

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026